BamSEC and AlphaSense Join Forces
Learn More

Recursion Pharmaceuticals Inc.

NASDAQ: RXRX    
Share price (12/20/24): $6.03    
Market cap (12/20/24): $1.728 billion

Indentures Filter

EX-4.6
from S-8 60 pages Recursion Pharmaceuticals, Inc. 2024 Inducement Equity Incentive Plan
12/34/56
EX-4.5
from S-8 85 pages Exscientia PLC 2021 Equity Incentive Plan With Non-Employee Sub-Plan and Csop Sub-Plan Adopted by the Board of Directors: 11 August 2021 Amended and Restated by the Board of Directors: 23 August 2021 Share Reserve Approved by the Pricing Committee of the Board of Directors: [Date] 2021 Ipo Date: [Date] 2021 Approved by the Shareholders: [Date] 2021
12/34/56
EX-4.4
from S-8 18 pages The Exscientia Unapproved Share Option Plan Plan Rules Adopted by the Board on 13th February 2018 and Amended on 25th September 2019 and 1st April 2021 Plan Rules
12/34/56
EX-4.2
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 11 pages Registration Agreement
12/34/56
EX-4.3
from S-3ASR 10 pages Registration Agreement
12/34/56
EX-4.2
from S-3ASR 26 pages Exchangeable Share Support Agreement
12/34/56
EX-4.4
from S-8 13 pages Cyclica Inc. Second Amended and Restated Stock Option Plan
12/34/56
EX-4.4
from S-8 15 pages Valence Discovery Inc. Stock Option Plan Dated April 17, 2018 as Amended and Restated on November 16, 2021
12/34/56
EX-4.3
from S-3ASR 53 pages Recursion Pharmaceuticals, Inc. Indenture Dated as of , 20 [ ] Trustee
12/34/56
EX-4.3
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from S-1 2 pages Indenture or similar
12/34/56
EX-4.1
from S-1 67 pages Recursion Pharmaceuticals, Inc. Amended and Restated Investors’ Rights Agreement September 1, 2020
12/34/56
EX-4.1
from DRS/A 67 pages Recursion Pharmaceuticals, Inc. Amended and Restated Investors’ Rights Agreement September 1, 2020
12/34/56